www.nytimes.com September 10, 2014
New Drug to Treat Obesity Gains Approval by F.D.A.
Medicare, most state Medicaid programs and some commercial insurers do not pay for the drugs. Doctors and patients are cautious about safety because of problems with previous weight loss drugs. And for many people, the weight loss is modest.Read the article on Nytimes